Christopher Kragor, MD
Oral and Maxillofacial Surgery · Marietta, GANPI 1194082321
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.6% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Zimvie Inc. at 50.5% of the total. Reporting peaked in 2024 at $702 and has fallen 86.3% since, to $96 in 2025.
Across 73 payments — averaging $41.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimvie Inc.$2K
- Zimmer Biomet$1K
- Pacira Pharmaceuticals Incorporated$235
- Biohorizons Implant Systems Inc.$30
- Kls-martin L.p.$22
- Nobel Biocare USA$16
What the payments were for
- Food & beverage$2,79993%
- Education$2237%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimvie Inc. | 36 | $1,525 |
| Zimmer Biomet | 32 | $1,194 |
| Pacira Pharmaceuticals Incorporated | 2 | $235 |
| Biohorizons Implant Systems Inc. | 1 | $30 |
| Kls-martin L.p. | 1 | $22 |
| Nobel Biocare USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$235
- T3$223
- OSSEOTITE NT$127
- Diem2-RevitaliZe$125
- All T3 Implants$121
- Diem2$103
How this compares
$3,022 in reported general payments places this provider in the 75th percentile of 236 oral and maxillofacial surgery providers in Georgia.
See all oral and maxillofacial surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 508 | $1,971 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 296 | $1,319 |
| Clindamycin Hcl | 191 | $1,269 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 151 | $885 |
| Ibuprofen | 272 | $838 |
| Amoxicillin | 67 | $160 |
| Lidocaine Hcl ViscousLidocaine Hcl | 18 | $121 |
| Tramadol Hcl | 16 | $24 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Marietta
- Paul SchanerMarietta$42K
- Jorge Gonzalez-OcasioMarietta$15K
- Christopher YiMarietta$9K
- Robert WunderleMarietta$8K
- Jonathan ThreadgillMarietta$7K
- Joshua LevyMarietta$6K
- Chris JoMarietta$5K
- Brad HarrisMarietta$4K
- Scott RoseMarietta$4K
- Richard KeimMarietta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.